470 filings
8-K
OPRX
OptimizeRx Corp
29 Apr 24
1Q24 revenue expected to grow over 40% year-over-year and come in between
4:30pm
ARS
2023 FY
OPRX
OptimizeRx Corp
29 Apr 24
Annual report to shareholders
8:38am
DEF 14A
OPRX
OptimizeRx Corp
Definitive proxy
29 Apr 24
8:35am
8-K
OPRX
OptimizeRx Corp
18 Apr 24
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
4:30pm
10-K
2023 FY
OPRX
OptimizeRx Corp
Annual report
15 Apr 24
4:41pm
8-K
5xqwhlkq
2 Apr 24
Entry into a Material Definitive Agreement
4:05pm
NT 10-K
ikkbuu7 pn
28 Mar 24
Notice of late annual filing
8:15am
8-K
ni9nsurck4c 9hw
11 Mar 24
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
5:04pm
8-K
git4500vrhvb w53u0
26 Jan 24
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
4:00pm
8-K/A
6viwdur
5 Jan 24
Financial Statements and Exhibits
5:19pm
8-K
qvvdq3s1i pcibqvk
6 Nov 23
OptimizeRx Reports Third Quarter 2023 Financial Results
7:15am
8-K
x1d89ymtl2lk8faxf
25 Oct 23
Entry into a Material Definitive Agreement
4:00pm
8-K
w7hb 6ogkx0p
16 Oct 23
OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers
4:31pm
8-K
4e5pgzv3m
14 Aug 23
OptimizeRx Reports Second Quarter 2023 Financial Results
4:05pm
8-K
3v4vu0ac 3x
7 Jun 23
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
tsb8gonpv56xe9f6 1v
10 May 23
OptimizeRx Reports First Quarter 2023 Financial Results
4:15pm